CHA Vaccine Research Institute (KOSDAQ:261780)
3,985.00
+125.00 (3.24%)
At close: Apr 28, 2026
KOSDAQ:261780 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | -16,044 | -10,138 | -1,749 | -6,715 | -18,420 | Upgrade
|
| Depreciation & Amortization | 455.64 | 491.22 | 533.31 | 417.36 | 245.49 | Upgrade
|
| Loss (Gain) From Sale of Investments | -263.18 | -66.77 | 40.4 | -105.84 | -125.77 | Upgrade
|
| Stock-Based Compensation | 68.7 | 61.53 | 118.92 | 444.39 | 451.81 | Upgrade
|
| Other Operating Activities | 3,708 | 3,789 | -2,286 | 1,240 | 12,783 | Upgrade
|
| Change in Other Net Operating Assets | 1,059 | -2,232 | -1,951 | -469.56 | 325.6 | Upgrade
|
| Operating Cash Flow | -11,017 | -8,096 | -5,293 | -5,189 | -4,740 | Upgrade
|
| Capital Expenditures | -116.84 | -179.21 | -278.58 | -447.4 | -679.57 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.88 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -39.08 | -55.37 | -12.21 | - | -3.66 | Upgrade
|
| Investment in Securities | 15,838 | 2,648 | 22,221 | 4,184 | -46,780 | Upgrade
|
| Other Investing Activities | 34.65 | -121.79 | - | -0 | - | Upgrade
|
| Investing Cash Flow | 15,718 | 2,291 | 21,930 | 3,736 | -47,463 | Upgrade
|
| Long-Term Debt Issued | - | 10,000 | 10,000 | - | - | Upgrade
|
| Total Debt Issued | - | 10,000 | 10,000 | - | - | Upgrade
|
| Long-Term Debt Repaid | -5,105 | -209.64 | -23,671 | -116.29 | -116.29 | Upgrade
|
| Total Debt Repaid | -5,105 | -209.64 | -23,671 | -116.29 | -116.29 | Upgrade
|
| Net Debt Issued (Repaid) | -5,105 | 9,790 | -13,671 | -116.29 | -116.29 | Upgrade
|
| Issuance of Common Stock | 87.38 | 199.9 | 554.71 | - | 44,436 | Upgrade
|
| Other Financing Activities | - | -0 | -0 | - | - | Upgrade
|
| Financing Cash Flow | -5,018 | 9,990 | -13,117 | -116.29 | 44,320 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | 0.17 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | -0 | - | - | Upgrade
|
| Net Cash Flow | -317.26 | 4,186 | 3,520 | -1,568 | -7,883 | Upgrade
|
| Free Cash Flow | -11,134 | -8,275 | -5,572 | -5,636 | -5,419 | Upgrade
|
| Free Cash Flow Margin | -7019.41% | -2232.46% | -1894.38% | -3140.08% | -1083.83% | Upgrade
|
| Free Cash Flow Per Share | -414.28 | -308.52 | -209.32 | -213.18 | -232.41 | Upgrade
|
| Cash Income Tax Paid | -64.87 | -168.01 | 288.65 | 85.97 | 17.07 | Upgrade
|
| Levered Free Cash Flow | -5,931 | -2,183 | -10,251 | -6,799 | -6,029 | Upgrade
|
| Unlevered Free Cash Flow | -4,586 | -1,378 | -8,607 | -5,195 | -4,703 | Upgrade
|
| Change in Working Capital | 1,059 | -2,232 | -1,951 | -469.56 | 325.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.